Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Sep-24 4:18 PM View:  | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 23-Sep-24 | Planned Option Sale | 1,500 | $38.67 | $58,005.00 | (9%) 16.9K to 15.4K | |
| 24-Sep-24 4:18 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 23-Sep-24 | Option Exercise | 1,500 | $18.50 | $27,750.00 | 10% 15.4K to 16.9K | |
| 17-Sep-24 6:44 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 17-Sep-24 | Planned Option Sale | 2,280 | $38.41 | $87,575.50 | (32%) 7.02K to 4.74K | |
| 17-Sep-24 6:44 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 17-Sep-24 | Sale (Planned) | 1,500 | $38.41 | $57,615.50 | (32%) 4.74K to 3.24K | |
| 17-Sep-24 6:44 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 16-Sep-24 | Planned Option Sale | 6,500 | $40.13 | $260,845.00 | (48%) 13.52K to 7.02K | |
| 17-Sep-24 6:41 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 16-Sep-24 | Planned Option Sale | 10,000 | $40.13 | $401,300.00 | (68%) 14.74K to 4.74K | |
| 17-Sep-24 6:44 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 16-Sep-24 | Option Exercise | 5,000 | $14.02 | $70,100.00 | 47% 10.74K to 15.74K | |
| 17-Sep-24 6:41 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 16-Sep-24 | Option Exercise | 10,000 | $20.16 | $201,600.00 | 144% 6.96K to 16.96K | |
| 17-Sep-24 6:44 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 16-Sep-24 | Option Sale | 2,220 | $38.93 | $86,424.60 | (14%) 15.74K to 13.52K | |
| 17-Sep-24 6:42 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 16-Sep-24 | Option Sale | 2,220 | $38.93 | $86,424.60 | (13%) 17.62K to 15.4K | |
| 17-Sep-24 6:41 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 16-Sep-24 | Option Sale | 2,220 | $38.93 | $86,424.60 | (13%) 16.96K to 14.74K | |
| 17-Sep-24 6:45 PM View: | Orwin John A Director | Anaptysbio, Inc (ANAB) | 15-Sep-24 | Option Exercise | 1,300 | -- | -- | 64% 2.04K to 3.33K | |
| 17-Sep-24 6:44 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 14-Sep-24 | Option Exercise | 6,000 | -- | -- | 127% 4.74K to 10.74K | |
| 17-Sep-24 6:42 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 14-Sep-24 | Option Exercise | 6,000 | -- | -- | 52% 11.62K to 17.62K | |
| 17-Sep-24 6:41 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 14-Sep-24 | Option Exercise | 6,000 | -- | -- | 622% 0.96K to 6.96K | |
| 16-Aug-24 12:04 PM View: | Ecor1 Capital, LLC 10% Owner | Anaptysbio, Inc (ANAB) | 14-Aug-24 | Market Purchase | 273,972 | $36.50 | $9,999,980.00 | 4% 7.52M to 7.79M | (7%) |
| 19-Jul-24 8:35 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 18-Jul-24 | Option Exercise | 1,500 | $18.50 | $27,750.00 | 13% 11.62K to 13.12K | |
| 19-Jul-24 8:35 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 18-Jul-24 | Planned Option Sale | 1,500 | $35.00 | $52,500.00 | (11%) 13.12K to 11.62K | |
| 17-Jul-24 4:45 PM View: | Renton Hollings Director | Anaptysbio, Inc (ANAB) | 15-Jul-24 | Planned Option Sale | 10,000 | $30.64 | $306,422.00 | (84%) 11.95K to 1.95K | |
| 17-Jul-24 4:45 PM View: | Renton Hollings Director | Anaptysbio, Inc (ANAB) | 15-Jul-24 | Option Exercise | 10,000 | $6.93 | $69,300.00 | 513% 1.95K to 11.95K | |
| 24-Jun-24 5:23 PM View: | Fenton Dennis M Director | Anaptysbio, Inc (ANAB) | 21-Jun-24 | Sale (Planned) | 1,950 | $23.17 | $45,181.50 | (50%) 3.9K to 1.95K | |
| 18-Jun-24 8:15 PM View: | Renton Hollings Director | Anaptysbio, Inc (ANAB) | 18-Jun-24 | Planned Option Sale | 1,950 | $23.16 | $45,162.00 | (50%) 3.9K to 1.95K | |
| 18-Jun-24 8:17 PM View: | Schmid John P. Director | Anaptysbio, Inc (ANAB) | 15-Jun-24 | Option Exercise | 3,900 | -- | -- | 100% 0 to 3.9K | |
| 18-Jun-24 8:15 PM View: | Orwin John A Director | Anaptysbio, Inc (ANAB) | 15-Jun-24 | Option Exercise | 2,035 | -- | -- | 100% 0 to 2.04K | |
| 18-Jun-24 8:17 PM View: | Marquet Magda Director | Anaptysbio, Inc (ANAB) | 15-Jun-24 | Option Exercise | 3,900 | -- | -- | 100% 0 to 3.9K | |
| 18-Jun-24 8:16 PM View: | Ware J. Anthony Director | Anaptysbio, Inc (ANAB) | 15-Jun-24 | Option Exercise | 3,900 | -- | -- | 108% 3.6K to 7.5K | |
| 18-Jun-24 8:15 PM View: | Renton Hollings Director | Anaptysbio, Inc (ANAB) | 15-Jun-24 | Option Exercise | 3,900 | -- | -- | 100% 0 to 3.9K | |
| 18-Jun-24 8:18 PM View: | Fenton Dennis M Director | Anaptysbio, Inc (ANAB) | 15-Jun-24 | Option Exercise | 3,900 | -- | -- | 100% 0 to 3.9K | |
| 18-Jun-24 8:14 PM View: | Jain Rita Director | Anaptysbio, Inc (ANAB) | 15-Jun-24 | Option Exercise | 4,534 | -- | -- | 100% 0 to 4.53K | |
| 24-May-24 4:12 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 22-May-24 | Sale (Planned) | 1,500 | $23.72 | $35,580.00 | (61%) 2.46K to 0.96K | |
| 26-Mar-24 8:10 PM View: | Faga Daniel CEO Director | Anaptysbio, Inc (ANAB) | 26-Mar-24 | Payment of Exercise | 347,441 | $21.60 | $7,504,730.00 | (46%) 749.09K to 401.65K | |
| 26-Mar-24 8:10 PM View: | Faga Daniel CEO Director | Anaptysbio, Inc (ANAB) | 25-Mar-24 | Sale | 3,000 | $21.42 | $64,267.50 | (< 1%) 752.09K to 749.09K | |
| 26-Mar-24 8:10 PM View: | Faga Daniel CEO Director | Anaptysbio, Inc (ANAB) | 22-Mar-24 | Sale | 145,940 | $22.78 | $3,325,180.00 | (16%) 898.03K to 752.09K | |
| 21-Feb-24 5:38 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 16-Feb-24 | Option Exercise | 5,000 | $14.02 | $70,100.00 | 154% 3.24K to 8.24K | |
| 21-Feb-24 5:38 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 16-Feb-24 | Planned Option Sale | 5,000 | $25.00 | $125,000.00 | (61%) 8.24K to 3.24K | |
| 01-Feb-24 5:27 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 30-Jan-24 | Sale (Planned) | 3,065 | $23.63 | $72,425.30 | (76%) 4.03K to 0.96K | |
| 09-Jan-24 7:08 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 08-Jan-24 | Option Sale | 2,554 | $21.81 | $55,702.70 | (20%) 12.67K to 10.12K | |
| 09-Jan-24 7:06 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 08-Jan-24 | Option Sale | 2,180 | $21.81 | $47,545.80 | (35%) 6.21K to 4.03K | |
| 09-Jan-24 7:07 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 08-Jan-24 | Option Sale | 2,305 | $21.81 | $50,272.00 | (42%) 5.54K to 3.24K | |
| 09-Jan-24 7:05 PM View: | Faga Daniel CEO Director | Anaptysbio, Inc (ANAB) | 08-Jan-24 | Option Sale | 6,866 | $21.81 | $149,747.00 | (< 1%) 904.89K to 898.03K | |
| 09-Jan-24 7:05 PM View: | Faga Daniel CEO Director | Anaptysbio, Inc (ANAB) | 06-Jan-24 | Option Exercise | 17,850 | -- | -- | 2% 887.04K to 904.89K | |
| 09-Jan-24 7:07 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 06-Jan-24 | Option Exercise | 5,545 | -- | -- | 100% 0 to 5.54K | |
| 09-Jan-24 7:08 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 06-Jan-24 | Option Exercise | 6,145 | -- | -- | 94% 6.53K to 12.67K | |
| 09-Jan-24 7:06 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 06-Jan-24 | Option Exercise | 5,245 | -- | -- | 544% 0.96K to 6.21K | |
| 27-Nov-23 4:03 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 22-Nov-23 | Sale (Planned) | 882 | $14.19 | $12,515.60 | (100%) 0.88K to 0 | |
| 18-Sep-23 6:13 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 18-Sep-23 | Planned Option Sale | 3,895 | $19.32 | $75,232.30 | (82%) 4.78K to 0.88K | |
| 18-Sep-23 6:12 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 18-Sep-23 | Planned Option Sale | 3,895 | $19.32 | $75,236.60 | (80%) 4.86K to 0.96K | |
| 18-Sep-23 6:14 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 14-Sep-23 | Option Exercise | 6,000 | -- | -- | 228% 2.63K to 8.63K | |
| 18-Sep-23 6:12 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 14-Sep-23 | Option Sale | 2,105 | $19.48 | $41,005.40 | (30%) 6.96K to 4.86K | |
| 18-Sep-23 6:13 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 14-Sep-23 | Option Exercise | 6,000 | -- | -- | 680% 0.88K to 6.88K |
